Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 10, 2000
Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysisJ Kyriazis, D Stamatiadis, A MamounaThe British Journal of Dermatology|November 1, 1988
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acidD Stamatiadis, M C Bulteau-Portois, I MowszowiczJournal of Steroid Biochemistry|January 1, 1989
Androgen receptor in sexual differentiationI Mowszowicz, D Stamatiadis, F Wright, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1995
The smoking-cessation promotion practices of physician smokers in GreeceA Polyzos, C Gennatas, M Veslemes, et al.Molecular and Cellular Endocrinology|December 1, 1987
Photoaffinity labeling of the androgen receptor from human skin fibroblastsD Stamatiadis, M C Portois, J P Blondeau, et al.The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1992
Isoelectric focusing and 2D electrophoresis of the human androgen receptorD Stamatiadis, F Dadoun, M C Portois, et al.Journal of Health Psychology|September 24, 2008
An investigation of the effects of music on anxiety and pain perception in patients undergoing haemodialysis treatmentM Pothoulaki, R A R Macdonald, P Flowers, et al.Journal of Chemotherapy (Florence, Italy)|May 29, 1998
Optimal duration of chemotherapy in small cell lung cancer: a randomized study of 4 versus 6 cycles of cisplatin-etoposideM Veslemes, A Polyzos, P Latsi, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 4, 2004
Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart diseaseN Tentolouris, D Doulgerakis, I Moyssakis, et al.Oncology|May 27, 1999
A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancerA Polyzos, N Tsavaris, C Kosmas, et al.Pageof 2